Recursion Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discov…

Biotechnology
US, Salt Lake City [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Recursion Pharmaceuticals, Inc. has no acquisition track records yet.

M&A Deals · History

Recursion Pharmaceuticals, Inc. has no acquisition track records yet.

End of RXRX's Analysis
CIK: 1601830 CUSIP: 75629V104 ISIN: US75629V1044 LEI: - UEI: -
Secondary Listings
RXRX has no secondary listings inside our databases.